The Essential Medicines List for Children currently presents a list of minimum medicine needs for a basic health care system, listing the most efficacious, safe and cost-effective medicines for priority conditions . Consisting of around 270 drugs identified by WHO, the formulary will cover the treatment of children from birth to 12 years and provide general guidance on the use of medicines for children utilising existing information from the current WHO Model Formulary. .
Priority conditions are selected on the basis of current and estimated future public health relevance, and potential for safe and costâ€Âeffective treatment. An additional and complementary list presents essential medicines for priority diseases, for which specialized diagnostic or monitoring facilities, and/or specialist medical care, and/or specialist training are needed. In case of doubt medicines may also be listed as complementary on the basis of consistent higher costs or less attractive cost-effectiveness in a variety of settings.
Work has already commenced on the project with completion expected by mid 2010. MIMS National Business Manager, Margaret Gehrig said ‘The MIMS Australia and Royal Children's Hospital work with WHO is a very exciting project that will ensure access to essential medicines information for healthcare professionals working with children in a wide range of countries including third world countries' . She added" we are extremely pleased to be partnering with the Royal Children's Hopsital to complete this very important piece of work".
UBM Medica provides information and education to healthcare professionals and patients around the world. It has a unique portfolio of professional media products including newspapers, magazines, drug directories, electronic databases, websites and events.
To learn more visit: http://www.cmpmedica.com